» Articles » PMID: 38153514

Quercetin Influences Intestinal Dysbacteriosis and Delays Alveolar Epithelial Cell Senescence by Regulating PTEN/PI3K/AKT Signaling in Pulmonary Fibrosis

Overview
Specialty Pharmacology
Date 2023 Dec 28
PMID 38153514
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary fibrosis is a chronic and progressive lung disease with high mortality. This study aims to explore the protective mechanism of quercetin against pulmonary fibrosis regarding cell senescence and gut microbiota. Rats were intratracheally injected with bleomycin (BLM) to establish a pulmonary fibrosis rat model. RLE-6TN cells were stimulated with BLM to build the model of alveolar epithelial cell senescence, and RLE-6TN-derived conditional medium (CM) was harvested to further culture fibroblasts. Histopathological changes were assessed by H&E and Masson staining. α-SMA expression was assessed by immunofluorescence assay. Senescence-associated β-galactosidase (SA-β-gal) staining and senescence-associated secretory phenotype (SASP) cytokine assay were conducted to assess cellular senescence. Gut microbiota was analyzed by 16S rRNA gene sequencing. The fibrosis-, senescence-, and PTEN/PI3K/AKT signaling-related proteins were examined by western blot. In BLM-induced pulmonary fibrosis rats, quercetin exerted its protective effects by reducing histological injury and collagen deposition, lessening cellular senescence, and regulating gut microbiota. In BLM-induced alveolar epithelial cell senescence, quercetin inhibited senescence, lessened SASP cytokine secretion of alveolar epithelial cells, and further ameliorated collagen deposition in fibroblasts. In addition, quercetin might exert its functional effects by regulating the PTEN/PI3K/AKT signaling pathway. Moreover, quercetin regulated intestinal dysbacteriosis in BLM-induced pulmonary fibrosis rats, especially boosting the abundance of Akkermansia. To conclude, our findings provide an in-depth understanding of the potential mechanism behind the protective role of quercetin against pulmonary fibrosis.

Citing Articles

Use quercetin for pulmonary fibrosis: a preclinical systematic review and meta-analysis.

Wu X, Xiao X, Su Y, Zhang Y, Li G, Wang F Inflammopharmacology. 2025; .

PMID: 40038212 DOI: 10.1007/s10787-025-01678-1.


Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions.

Vithalkar M, Pradhan S, Sandra K, Bharath H, Nayak Y Cell Biochem Biophys. 2025; .

PMID: 39966334 DOI: 10.1007/s12013-025-01696-4.


Quercetin prevents the loss of chondrogenic capacity in expansion cultured human auricular chondrocytes by alleviating mitochondrial dysfunction.

Tong H, Guo X, Chen L, Wang H, Hu X, He A Regen Ther. 2025; 28:358-370.

PMID: 39896443 PMC: 11783217. DOI: 10.1016/j.reth.2025.01.005.


The Role of Quercetin, a Flavonoid in the Management of Pathogenesis Through Regulation of Oxidative Stress, Inflammation, and Biological Activities.

Alharbi H, Alshebremi M, Babiker A, Rahmani A Biomolecules. 2025; 15(1).

PMID: 39858545 PMC: 11763763. DOI: 10.3390/biom15010151.


[Quercetin suppresses pyroptosis in mouse fibroblasts by inhibiting the NLRP3/caspase-1/GSDMD pathway].

Shu P, Yuan M, Yang K, He W, Liu L Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(10):1874-1880.

PMID: 39523087 PMC: 11526465. DOI: 10.12122/j.issn.1673-4254.2024.10.05.


References
1.
Alvarez D, Cardenes N, Sellares J, Bueno M, Corey C, Hanumanthu V . IPF lung fibroblasts have a senescent phenotype. Am J Physiol Lung Cell Mol Physiol. 2017; 313(6):L1164-L1173. PMC: 6148001. DOI: 10.1152/ajplung.00220.2017. View

2.
Boots A, Veith C, Albrecht C, Bartholome R, Drittij M, Claessen S . The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice. BMC Pulm Med. 2020; 20(1):112. PMC: 7191795. DOI: 10.1186/s12890-020-1142-x. View

3.
Budden K, Gellatly S, Wood D, Cooper M, Morrison M, Hugenholtz P . Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2016; 15(1):55-63. DOI: 10.1038/nrmicro.2016.142. View

4.
Chioma O, Hesse L, Chapman A, Drake W . Role of the Microbiome in Interstitial Lung Diseases. Front Med (Lausanne). 2021; 8:595522. PMC: 7885795. DOI: 10.3389/fmed.2021.595522. View

5.
Dang A, Marsland B . Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019; 12(4):843-850. DOI: 10.1038/s41385-019-0160-6. View